Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, July 16, 2018

Fire prevention in the Parkinson’s disease brain

With your chances of getting Parkinsons post stroke you'll want to ask your doctor what is being done to prevent that. S/he has had a year to come up with Parkinsons prevention and I bet nothing has been done on that.

Parkinson’s Disease May Have Link to Stroke March 2017 

The latest here:

 Fire prevention in the Parkinson’s disease brain


Nature Medicine volume 24, pages900–902 (2018) | Download Citation

A glucagon-like peptide receptor 1 (GLP-1R) agonist inhibits the conversion of astrocytes into a neurotoxic phenotype and protects against neurodegeneration, shedding light on the pathogenesis of Parkinson’s disease.

Access options

Rent or Buy article
Get time limited or full article access on ReadCube.
from $8.99
All prices are NET prices.
Subscribe to Journal
Get full journal access for 1 year
$225.00
only $18.75 per issue

Posted by at
Labels: , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)